The Light-weight Mid-urethral Sling Implant for Female Stress Urinary Incontinence Treatment: A One-Year Postoperative Follow-up Study.

Isr Med Assoc J

Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Published: January 2023

AI Article Synopsis

  • Serasis® is a lightweight mid-urethral sling designed for treating stress urinary incontinence (SUI), with less traumatic insertion compared to other similar devices.
  • The study evaluated postoperative outcomes in 50 patients who received the Serasis implant, focusing on early pain, symptom relief, and complications up to one year after surgery.
  • Results showed that the majority of patients (90% at one month and 92% at one year) were free of SUI symptoms, with mild postoperative pain and a low incidence of complications reported.

Article Abstract

Background: Serasis® (Serag-Wiessner KG, Naila, Germany) is a light-weight mid-urethral sling for treating stress urinary incontinence (SUI). Its insertion is considered less traumatic than other mid-urethral slings.

Objectives: To define postoperative outcomes following Serasis implantation. To compare the efficacy and complication rates of the implant to those of other common techniques.

Methods: Our retrospective study evaluated patients who underwent Serasis mid-urethral sling surgery for SUI. Data were collected from medical records prior to and at the time of surgery and by telephonic interview for postoperative pain and complications. Follow-up of patients was performed for up to one year postoperatively. Patients rated pain or discomfort according to the Visual Analogue Scale (VAS). The primary outcome was the development of early postoperative pain during the first month after surgery. Secondary outcomes were relief of SUI symptoms, groin pain or discomfort, and other postoperative complications up to 12 months after surgery.

Results: The study cohort included 50 consecutive patients aged 31 to 68 years. All patients underwent Serasis implantation procedures by a single surgeon and completed interviews. In total, 35 patients underwent concomitant anterior colporrhaphy. In the immediate postoperative period and at one month after the procedure, complaints were mild. No complaints were recorded during the 12-month follow-up period. Overall, 90% and 92% of the patients were free of SUI symptoms at one month and 12 months after surgery, respectively.

Conclusions: Serasis mid-urethral sling is safe, effective, and associated with mild postoperative pain and a low incidence of complications.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mid-urethral sling
16
patients underwent
12
postoperative pain
12
light-weight mid-urethral
8
stress urinary
8
urinary incontinence
8
serasis implantation
8
underwent serasis
8
serasis mid-urethral
8
pain discomfort
8

Similar Publications

Purpose: To evaluate two primary outcomes in elite female athletes (EFAs) with severe stress urinary incontinence (SUI) 24 months post-intervention: return to elite-level competition and improvement in SUI symptoms. Clustering analysis was conducted to identify subgroups within the patient population and explore treatment efficacy.

Methods: A retrospective analysis was performed on 183 EFAs with severe SUI who underwent treatments including pelvic floor muscle training (PFMT), vaginal and urethral erbium laser (Fotona Laser), and mid-urethral sling (MUS) surgery.

View Article and Find Full Text PDF

Introduction And Hypothesis: Various treatment options are currently available for the management of stress urinary incontinence (SUI). This study was aimed at determining the effectiveness and safety profile of Bulkamid, and identify predictive factors of clinical success.

Methods: This retrospective study conducted in two French urogynecology university centers between September 2019 and December 2023 included all patients with urinary incontinence who received Bulkamid.

View Article and Find Full Text PDF

Stress urinary incontinence (SUI) is a common disorder in females, which significantly affects the quality of life in females. There are many consensus that describe the safety of childbearing after surgery for SUI, but still, a large proportion of surgeons worldwide recommend that women should wait to complete childbearing before pursuing surgical treatment for SUI. There is also some opinion that if patients conceive after surgical treatment for SUI, women should be delivered by cesarean section.

View Article and Find Full Text PDF
Article Synopsis
  • * A comprehensive search across multiple databases identified 13 high-quality randomized controlled trials to assess cure rates and complications associated with both surgical methods.
  • * Results showed that both TVT and TVT-O had similar mid- to long-term cure rates for SUI, but TVT was linked to a higher risk of hematoma and a lower risk of thigh/groin pain compared to TVT-O.
View Article and Find Full Text PDF

Comparative Analysis of the Efficacy of Different Surgical Modalities for the Treatment of Female Stress Urinary Incontinence: A Multicenter Retrospective Study.

Int J Womens Health

November 2024

Department of Gynecology, Minda Hospital of Hubei Minzu University, Enshi, Enshi Tujia and Miao Autonomous Prefecture, Hubei, People's Republic of China.

Article Synopsis
  • The study aimed to compare the effectiveness of four surgical techniques for treating female stress urinary incontinence (SUI) using a sample of 243 patients divided into four groups based on the method used: AFS, TVT-O, epithelial flap suspension, and ASIS.
  • Results showed no significant differences in treatment outcomes across the groups, but the ASIS group had better metrics in terms of reduced intraoperative bleeding and shorter hospital stays compared to others.
  • The TVT-O technique was associated with a higher occurrence of postoperative medial thigh pain, while the AFS group had more cases of urine retention, highlighting the different risk profiles of each surgical method despite overall effectiveness.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!